NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10411	Companies
217811	Keywords
147360	Articles
115249	Press releases

Home
Companies
NANOBIOTIX

PRESS RELEASE

published on 03/20/2025 at 21:15, 1 year 1 month ago

NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
Nanobiotix announces presentation of data from two Phase 1 studies evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference. Studies highlight safety, efficacy, and collaboration strategies

Collaboration NANOBIOTIX Lung Cancer JNJ-1900 Phase 1 Studies
BRIEF

published on 03/17/2025 at 21:20, 1 year 1 month ago

NANOBIOTIX Prolonge son Horizon Financier jusqu'à mi-2026

Accord De Licence NANOBIOTIX NBTXR3 Visibilité Financière Janssen
BRIEF

published on 03/17/2025 at 21:20, 1 year 1 month ago

NANOBIOTIX Extends its Financial Horizon until mid-2026

License Agreement NANOBIOTIX NBTXR3 Financial Visibility Janssen
PRESS RELEASE

published on 03/17/2025 at 21:15, 1 year 1 month ago

NANOBIOTIX renforce sa visibilité financière en amendant son accord de licence globale pour JNJ-1900 (NBTXR3) qui étend son horizon de trésorerie jusqu’à mi-2026
Nanobiotix renforce sa visibilité financière en amendant son accord de licence avec JNJ-1900 (NBTXR3), étendant son horizon de trésorerie jusqu’à mi-2026. Conférence le 18/03/2025

Trésorerie Accord De Licence NANOBIOTIX Visibilité Financière JNJ-1900
PRESS RELEASE

published on 03/17/2025 at 21:15, 1 year 1 month ago

NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
Nanobiotix strengthens financial position by amending global licensing agreement for JNJ-1900 (NBTXR3), extending cash visibility to mid-2026. Details of the amendment and future potential milestone payments outlined

Financial Position Milestone Payments NANOBIOTIX JNJ-1900 Global Licensing Agreement
BRIEF

published on 03/13/2025 at 22:20, 1 year 2 months ago

Nanobiotix Reports Voting Rights and Share Capital Details

Euronext Paris Voting Rights Financial Transparency NANOBIOTIX Shares Outstanding
BRIEF

published on 03/13/2025 at 22:20, 1 year 2 months ago

Nanobiotix publie les détails de ses droits de vote et de son capital social

Euronext Paris Droit De Vote Transparence Financière Actions En Circulation NANOBIOTIX
PRESS RELEASE

published on 03/13/2025 at 22:15, 1 year 2 months ago

Voting Rights and Shares Capital of the Company
Nanobiotix reports voting rights and shares capital. Detailed breakdown of outstanding shares and voting rights presented. Company overview and contact information included

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
PRESS RELEASE

published on 03/13/2025 at 22:15, 1 year 2 months ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Nanobiotix communique sur le nombre total d'actions et de droits de vote. Informations boursières et présentation de l'entreprise de biotechnologie

Droits De Vote Euronext Biotechnologie Actions NANOBIOTIX
BRIEF

published on 02/12/2025 at 22:20, 1 year 3 months ago

Nanobiotix : Détails sur les Droits de Vote et Actions en Janvier 2025

Euronext Paris Droits De Vote Actions Nasdaq NANOBIOTIX

Accesswire

Published on 05/16/2026 at 01:15, 7 hours 32 minutes ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 7 hours 47 minutes ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 8 hours 47 minutes ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 9 hours 37 minutes ago

Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 9 hours 47 minutes ago

Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency

View all ACCESSWIRE

EQS Group

Published on 05/15/2026 at 20:10, 12 hours 37 minutes ago

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:30, 14 hours 17 minutes ago

Designated Person Notifications
Published on 05/15/2026 at 18:30, 14 hours 17 minutes ago

Designated Person Notifications
Published on 05/15/2026 at 18:10, 14 hours 37 minutes ago

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 17:33, 15 hours 14 minutes ago

Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio

Les Echos

Published on 05/15/2026 at 15:08, 17 hours 39 minutes ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 17 hours 47 minutes ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 22 hours 38 minutes ago

Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 1 day 23 hours ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 2 days 14 hours ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES

View all LES ECHOS COMFI WIRE